In terms of general use for treating obesity or overweight conditions with accompanying health risks, evidence suggests that Wegovy performs similarly to placebo plus lifestyle intervention for achieving clinically meaningful weight loss after one year
GLP-1 medications like semaglutide (Wegovy, Ozempic) or the dual agonist tirzepatide (Zepbound, Mounjaro) reduce appetite and slow gastric emptying, making it easier to eat less without constant hunger
It integrates into your body. He also notes that many hyaluronic acid fillers can improve the look of hydration because HA is a natural moisture-binding substance
These physiological differences mean that weight management interventions may interact with female biology in ways that require specific consideration
Recently, however, GLP-1 receptor agonists forced the conversation into the open
If you are seeking a more holistic or functional approach to weight loss, click the link below to book a consultation and talk with one of our providers